Détail de l'auteur
Auteur Voit T |
Documents disponibles écrits par cet auteur (239)
trié(s) par (Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) | Mettre toutes les notices dans le panier | Faire une suggestion | Ajouter un critère de recherche
Article
Gruszczynski C ; Ziaei S ; Griffith G ; Precigout G ; Vulin A ; Dreyfus P ; Voit T ; Garcia L | 2011The analysis of DMD/BMD databases, which include patient records have allowed to assess the proportion of DMD patients that is eligible for exon skipping strategies as well as to appraise the impact of various exon skipping events. Among them, t[...]Article
Delague V ; Bourgeois P ; Krahn M ; Cossee M ; Orrhant L ; Leturcq F ; Chelly J ; Guittard C ; Beroud C ; Allamand V ; Bonne G ; Nelson I ; Richard P ; Voit T | 2011Currently, in most laboratories, molecular explorations in neuromuscular disorders (NMDs) are based on a differential molecular genotyping by a complex and time consuming gene by gene approach. As a consequence, it is estimated that 35-50 % of p[...]Article
Larcher T ; François V ; Le Guiner C ; Deschamps JY ; Guigand L ; Dutilleul M ; Betti E ; Montus M ; Servais L ; Voit T ; Moullier P | 2011In Duchenne Muscular Dystrophy (DMD) the selective removal by exon skipping of exons flanking an out-of frame mutation in the dystrophin messenger can result in in-frame mRNA transcripts that are translated into shorter but functionally active d[...]Article
Article
Treves S ; Vukcevic M ; Jeannet PY ; Levano S ; Girard T ; Urwyler A ; Fischer D ; Voit T ; Jungbluth H ; Lillis S ; Muntoni F ; Quinlivan R ; Sarkozy A ; Bushby K ; Zorzato F | 2011Article
Dominguez E ; Marais T ; Chatauret N ; Benkhelifa Ziyyat S ; Duque S ; Ravassard P ; Carcenac R ; Astord S ; Pereira de Moura A ; Voit T ; Barkats M | 201119/01/2011 - Efficacité d'une seule injection intraveineuse d'un AAV9 portant une séquence SMN1 optimisée dans des souris modèles d'amyotrophie spinale proximale Les amyotrophies spinales proximales (SMA) sont caractérisées par une perte des [...]Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Le Bihan MC ; Bigot A ; Jensen SS ; Dennis JL ; Rogowska-Wrzesinska A ; Laine J ; Gache V ; Furling D ; Jensen ON ; Voit T ; Mouly V ; Coulton GR ; Butler Browne G | 2011Efficient muscle regeneration requires cross talk between multiple cell types via secreted signalling molecules. However, as yet there has been no comprehensive analysis of this secreted signalling network in order to understand how it regulates[...]Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Chaouch S ; Mamchaoui K ; Trollet C ; Bigot A ; Negroni E ; Wolff A ; Kandalla P ; Marie S ; Di Santo J ; Muntoni F ; Lacau Saint Guily J ; Spuler S ; Philippi S ; Blumen S ; Furling D ; Voit T ; Wright W ; Aamiri A ; Butler-Browne GS ; Mouly V ; Kandalla PK ; Kim J ; Blumen SC ; Wright WE | AFM-TELETHON | 2011We recently generated immortalized human myoblast cell lines from control donors, by transduction of these cells with both telomerase (hTERT) and cyclin-dependent kinase 4 (CDK-4) expressing vectors. These cells maintain their potential to diffe[...]Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Cherel Y ; Larcher T ; Deschamps JY ; Dutilleul M ; Guigand L ; Le Guiner C ; François V ; Montus M ; Servais L ; Voit T ; Moullier P | 2011In Duchenne Muscular Dystrophy (DMD) the selective removal by exon skipping of exons flanking an out-of frame mutation in the dystrophin messenger can result in in-frame mRNA transcripts that are translated into shorter but functionally active d[...]Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Gentil C ; Mouisel E ; Amthor H ; Ferry A ; Voit T ; Garcia L ; Pietri Rouxel F | AFM-TELETHON | 2011In skeletal muscle, the _1 S subunit of the DHPR calcium channel functions both as the L-type Ca2+ channel and the voltage sensor for excitation-contraction coupling. We have combined optimized U7snRNA and gene transfer to achieve long-lasting d[...]Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Bucher T ; Joussemet B ; Astord S ; Briot-Nivard D ; Wakeling E ; Fyfe J ; Costiou P ; Marais T ; Hogrel JY ; Voit T ; Moullier P ; Barkats M | 2011Domestic cats exhibiting a recessive form of lower motor neuron (MN) degeneration, associated with a deletion of the lix1 gene, represent a large animal model of type III spinal muscular atrophy (SMA). In this study, we first analyzed the effici[...]Article
Hentati F ; Rigolet A ; Behin A ; Romero NB ; France L ; Pascal L ; Maisonobe T ; Amouri R ; Haddad H ; M.Audit ; Montus M ; Masurier C ; Gjata B ; Georger C ; Cherai M ; Carlier P ; Hogrel JY ; Herson A ; Lemoine FM ; Klatzmann D ; Sweeney L ; Mulligan RC ; Eymard B ; Caizergues D ; Voit T ; Herson S | AFM-TELETHON | 2011BACKGROUND Gamma-sarcoglycanopathy or limb girdle muscular dystrophy type 2C (LGMD 2C) is an untreatable disease caused by autosomal recessively inherited mutations of the -sarcoglycan gene (SGC). METHODS Nine non-ambulatory LGMD2C patients (2 M[...]Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Pinto Mariz F ; Barthelemy I ; Yada E ; Voit T ; Silva-Barbosa SD ; Savino W ; Butler Browne G ; Blot S | 2011It is well known that the disease course in Duchenne muscular dystrophy (DMD) patients is heterogeneous, varying from patient to patient. Such heterogeneity is also seen in the Golden Retriever Muscular Dystrophy (GRMD) dogs. This is a drawback [...]Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Denard J ; Beley C ; Kotin R ; Samulski J ; Moullier P ; Voit T ; Garcia L ; Svinartchouk F | 2011Despite the well-established safety and efficacy of rAAV vectors for in vivo gene transfer, there is still little information concerning the fate of vectors after systemic delivery. By using a proteomic approach, we screened for serum proteins i[...]Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Vassilopoulos S ; Gentil C ; Laine J ; Buclez PO ; Brodsky F ; Bonne G ; Voit T ; Garcia L ; Pietri Rouxel F ; Bitoun M | AFM-TELETHON | 2011Clathrin CHC17, the ubiquitous clathrin heavy chain encoded on human chromosome 17, is the main component of clathrin coated vesicles (CCV), well characterized for its role in vesicle formation during endocytosis of membrane receptors from the p[...]Article
Mamchaoui K ; Trollet C ; Bigot A ; Negroni E ; Chaouch S ; Wolff A ; Kandalla PK ; Marie S ; Di Santo J ; Lacau Saint Guily J ; Muntoni F ; Kim J ; Philippi S ; Spuler S ; Blumen SC ; Voit T ; Wright WE ; Aamiri A ; Butler-Browne GS ; Mouly V | 2011Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Robin V ; Ittig D ; Voit T ; Leumann CJ ; Garcia L | AFM-TELETHON | 2011Spinal muscular atrophy is a recessive disease caused by mutations in the SMN1 gene, which encodes a protein (SMN) involved in RNA processing whose absence dramatically affects the survival of motor neurons. In Man, the severity of the disease i[...]Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Schumperli D ; Nlend Nlend R ; Huo Q ; Neve A ; Cudré-Mauroux F ; Meyer K ; Heller M ; Voit T ; Saxena S | AFM-TELETHON | 2011Spinal Muscular Atrophy (SMA) is characterised by the degeneration of motor neurons in the spinal cord and results from a loss of function (usually a deletion) of the SMN1 (Survival Motor-Neuron 1) gene. The highly similar SMN2 gene partly compe[...]Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Lorain S ; Peccate C ; Le Hir M ; Griffith G ; Voit T ; Garcia L | 2011Mutations in the dystrophin gene cause Duchenne muscular dystrophy, the most common severe childhood muscular pathology. With antisense sequences linked to a modified U7 small nuclear RNA, we achieved persistent exon skipping that removes the mu[...]Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Buyse G ; Voit T ; Schara U ; Verschuuren J ; Bernert G ; Jeannet P ; Sejersen T ; Rubino R ; Meier T | 2011Respiratory complications cause early morbidity and mortality in patients with Duchenne muscular dystrophy (DMD). The use of glucocorticoids slows the decline in respiratory function, but their long-term use is hampered by significant side effec[...]Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Hogrel JY ; Benali M ; Canal A ; Moraux A ; De Coninck N ; Desguerre I ; Quijano Roy S ; Estournet B ; Mayer M ; Thémar-Noël C ; Voit T ; Servais L | AFM-TELETHON | 2011Disease progression in children with neuromuscular disorder is frequently assessed by the 6-min walk test, which classically constitutes the clinical primary outcome in the present therapeutic trials. However, assessing the muscle function in no[...]Article
Claeys KG ; Sozanska M ; Martin JJ ; Lacene E ; Vignaud L ; Stockholm D ; Laforet P ; Eymard B ; Kichler A ; Scherman D ; Voit T ; Israeli D | 2010Accès au résumé Pubmed/to pubmed abstractArticle
Knoblauch H ; Geier C ; Adams S ; Budde B ; Rudolph A ; Zacharias U ; Schulz-Menger J ; Spuler A ; Ben Yaou R ; Nurnberg P ; Voit T ; Bonne G ; Spuler S | 01/2010Accès au résumé PubMed / to PubMed abstractArticle
Cirak S ; von Deimling F ; Sachdev S ; Errington WJ ; Herrmann R ; Bonnemann CG ; Brockmann K ; Hinderlich S ; Lindner TH ; Steinbrecher A ; Hoffmann K ; Prive GG ; Hannink M ; Nurnberg P ; Voit T | 2010Accès au résumé PubMed / to PubMed abstractArticle
Pietri Rouxel F ; Gentil C ; Vassilopoulos S ; Baas D ; Mouisel E ; Ferry A ; Vignaud A ; Hourde C ; Marty I ; Schaeffer L ; Voit T ; Garcia L | 2010Accès au résumé PubMed / to PubMed abstract 09/03/2010 - Découverte d’un nouveau rôle du récepteur aux dihydropyridines Le récepteur aux dihydropyridines (DHPR) également appelé sous-unité alpha 1S, est l’une des cinq sous-unités [...]